The overarching objective of our work is to provide an inexpensive and scalable m-health tool to increase both volume and intensity of physical activity and reduce sedentary behavior in patients at risk for type 2 diabetes. The objective of this study is to pilot test MapTrek, a text-messaging based intervention.
This study will randomize participants to 2 groups, an intervention group that will receive a Fitbit and MapTrek, and a control group that will receive a Fitbit only. This study has 3 specific aims. Aim 1- To determine if patients randomized to MapTrek walk more than the control patients. Aim 2- To determine if patients randomized to MapTrek generally walk at a faster pace during the day than control patients. Aim 3- To determine if patients randomized to MapTrek have less sedentary time during the day than the control patients. We expect to collect sufficient data to demonstrate the effectiveness of MapTrek, our prototype m-health tool, as an intervention to increase physical activity, heighten intensity of activity, and reduce sedentary behavior among a cohort of patients at risk for type 2 diabetes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
430
Signal Center Innovation Lab
Coralville, Iowa, United States
Total number of steps per day
The Fitbit will provide the total number of steps that each patient has taken per day.
Time frame: 6 months
Pace of steps per day
The Fitbit will provide the number of steps taken per minute (pace) per day.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.